Skip to main content
OpenTrials

Clinical trial condition

Seizures

Explore clinical trials studying Seizures. Study availability and eligibility vary by location and protocol.

546 public trials 84 recruiting studies
Refine in advanced search Browse all conditions

Seizures trial results

Completed

Study of Adjunctive Ganaxolone Treatment in Children and Young Adults With CDKL5 Deficiency Disorder

NCT03572933

Conditions
Brain Diseases, CDKL5 Deficiency Disorder, CDKL5 deficiency disorder, +7 more
Locations
  • Marinus Research Site Phoenix, Arizona, United States
  • Marinus Research Site Los Angeles, California, United States
  • Marinus Research Site Aurora, Colorado, United States
  • Marinus Research Site Gulf Breeze, Florida, United States
View all 36 locations
View Trial Details
Completed

A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures

NCT00465517

Conditions
Brain Diseases, Catamenial Epilepsy, Central Nervous System Diseases, +8 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • Arkansas Epilepsy Program Little Rock, Arkansas, United States
  • University of Southern California Adult Comprehensive Epilepsy Center Los Angeles, California, United States
View all 27 locations
View Trial Details
Completed

Study to Investigate Safety and Tolerability of Intravenous Lacosamide in Children.

NCT02710890

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsy, +5 more
Locations
  • Ep0060 003 Birmingham, Alabama, United States
  • Ep0060 010 Little Rock, Arkansas, United States
  • Ep0060 008 Loxahatchee Groves, Florida, United States
  • Ep0060 009 Saint Paul, Minnesota, United States
View all 23 locations
View Trial Details
Completed

Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension

NCT01963208

Conditions
Brain Diseases, Central Nervous System Diseases, Drug Resistant Partial Onset Seizure, +7 more
Locations
  • University of Alabama Epilepsy Center Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Xenoscience Inc. Phoenix, Arizona, United States
  • The MORE Foundation Sun City, Arizona, United States
View all 71 locations
View Trial Details
Completed

A Study to Investigate Dosage, Effectiveness, and Safety of Perampanel When Used as First Add-on Therapy in Participants >=12 Years With Partial Onset Seizures With or Without Secondary Generalization or With Primary Generalized Tonic-Clonic Seizures Associated With Idiopathic Generalized Epilepsy

NCT04252846

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsy, +11 more
Locations
  • Sydvestjysk Sygehus Esbjerg Esbjerg, Region Syddanmark, Denmark
  • Hôpital Pontchaillou Rennes, Ille-et-Vilaine, France
  • Hôpital Roger Salengro Lille, Nord, France
  • Centre de consultations Saint-Jean Bâtiment A Cagnes-sur-Mer, France
View all 36 locations
View Trial Details
Completed

Open-label Extension to Protocol 1042-0600

NCT00512317

Conditions
Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +6 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • Arkansas Epilepsy Program Little Rock, Arkansas, United States
  • University of Southern California Adult Comprehensive Epilepsy Center Los Angeles, California, United States
View all 25 locations
View Trial Details

Related conditions